MX9400563A - Diarilalquil piperidinas utiles como agentes en tumores resistentes a la administracion de farmacos multiples. - Google Patents
Diarilalquil piperidinas utiles como agentes en tumores resistentes a la administracion de farmacos multiples.Info
- Publication number
- MX9400563A MX9400563A MX9400563A MX9400563A MX9400563A MX 9400563 A MX9400563 A MX 9400563A MX 9400563 A MX9400563 A MX 9400563A MX 9400563 A MX9400563 A MX 9400563A MX 9400563 A MX9400563 A MX 9400563A
- Authority
- MX
- Mexico
- Prior art keywords
- diarilalquil
- pharmaces
- administration
- agents
- tumors
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 150000003053 piperidines Chemical class 0.000 title abstract 2
- 102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 abstract 1
- 206010059866 Drug resistance Diseases 0.000 abstract 1
- 108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000005748 tumor development Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US656993A | 1993-01-21 | 1993-01-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9400563A true MX9400563A (es) | 1994-07-29 |
Family
ID=21721516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9400563A MX9400563A (es) | 1993-01-21 | 1994-01-20 | Diarilalquil piperidinas utiles como agentes en tumores resistentes a la administracion de farmacos multiples. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5648365A (enExample) |
| EP (1) | EP0680470B1 (enExample) |
| JP (1) | JP3398748B2 (enExample) |
| KR (1) | KR100377280B1 (enExample) |
| AT (1) | ATE150748T1 (enExample) |
| AU (1) | AU679723B2 (enExample) |
| CA (1) | CA2152794C (enExample) |
| DE (1) | DE69309310T2 (enExample) |
| DK (1) | DK0680470T3 (enExample) |
| ES (1) | ES2102830T3 (enExample) |
| FI (1) | FI112474B (enExample) |
| GR (1) | GR3023188T3 (enExample) |
| HU (1) | HUT72078A (enExample) |
| IL (1) | IL108369A (enExample) |
| MX (1) | MX9400563A (enExample) |
| NO (1) | NO305166B1 (enExample) |
| NZ (1) | NZ261414A (enExample) |
| TW (1) | TW243445B (enExample) |
| WO (1) | WO1994017040A1 (enExample) |
| ZA (1) | ZA94317B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU662602B2 (en) * | 1992-02-06 | 1995-09-07 | Merrell Dow Pharmaceuticals Inc. | Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives |
| AU6366000A (en) * | 1999-07-23 | 2001-02-13 | Colorado State University Research Foundation | Multidrug resistance pump inhibitors and uses thereof |
| US6693099B2 (en) | 2000-10-17 | 2004-02-17 | The Procter & Gamble Company | Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
| US6376514B1 (en) | 2000-10-17 | 2002-04-23 | The Procter & Gamble Co. | Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof |
| BR0213989A (pt) * | 2001-11-07 | 2005-03-01 | Pharmacia Corp | Métodos para promover a absorção e acúmulo nuclear de poliamidas em células eucarióticas |
| US8153184B2 (en) * | 2001-11-26 | 2012-04-10 | Samsung Mobile Display Co., Ltd. | Organic EL display device and method of manufacturing the same |
| KR100656490B1 (ko) * | 2001-11-26 | 2006-12-12 | 삼성에스디아이 주식회사 | 풀칼라 유기전계 발광표시소자 및 그의 제조방법 |
| PT2956440T (pt) | 2013-02-08 | 2018-05-08 | Gen Mills Inc | Produtos alimentares com baixo teor de sódio |
| CN110372571B (zh) * | 2018-04-12 | 2022-11-15 | 中国科学院大连化学物理研究所 | 一种2-(2,2-二芳基乙基)-环胺衍生物或盐及合成和应用与组合物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1049377B (de) * | 1952-04-03 | 1959-01-29 | Abbott Laboratories, North Chicago, 111. (V. St. A.) | Verfahren zur Herstellung von substituierten Vinylpiperidinen |
| US2898339A (en) * | 1957-07-29 | 1959-08-04 | Wm S Merrell Co | N-substituted benzhydrol, benzhydryl, and benzhydrylidene piperidine |
| US3956296A (en) * | 1974-12-11 | 1976-05-11 | A. H. Robins Company, Incorporated | 1-Substituted-4-benzylpiperidines |
| US4035372A (en) * | 1976-08-13 | 1977-07-12 | G. D. Searle & Co. | 4-{[4-(Diphenylmethyl)-1-piperidinyl]methyl}benzenamines |
| EP0228893A3 (en) * | 1985-12-20 | 1990-01-03 | A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) | Arylalkyl-heterocyclic amines, n-substituted by aryloxyalkyl group in allergy treatment |
| US4851423A (en) * | 1986-12-10 | 1989-07-25 | Schering Corporation | Pharmaceutically active compounds |
| US4990511A (en) * | 1988-08-03 | 1991-02-05 | Takeda Chemical Industries, Ltd. | Amide compounds, their production and use |
| DK0409406T3 (da) * | 1989-06-19 | 1994-02-07 | Wellcome Found | Arylsubstituerede aminderivater, der er anvendelige ved cancerterapi |
| GB9000305D0 (en) * | 1990-01-06 | 1990-03-07 | Pfizer Ltd | Anticholinergic agents |
| EP0467435A3 (en) * | 1990-07-19 | 1992-04-01 | Akzo N.V. | Benzhydryl derivatives having calmodulin inhibitor properties |
| DE69128820T2 (de) * | 1990-08-14 | 1998-06-10 | Hoechst Marion Roussel Inc | Neue 19-Nor Steroide, die eine Amid tragende Gruppe in der 11-Beta-Stelle haben, ihre Herstellung, ihre Verwendung als Medikamente und pharmazeutische Präparate davon |
| AU662602B2 (en) * | 1992-02-06 | 1995-09-07 | Merrell Dow Pharmaceuticals Inc. | Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives |
-
1993
- 1993-12-17 AT AT94906446T patent/ATE150748T1/de not_active IP Right Cessation
- 1993-12-17 DK DK94906446.3T patent/DK0680470T3/da active
- 1993-12-17 EP EP94906446A patent/EP0680470B1/en not_active Expired - Lifetime
- 1993-12-17 JP JP51701194A patent/JP3398748B2/ja not_active Expired - Fee Related
- 1993-12-17 ES ES94906446T patent/ES2102830T3/es not_active Expired - Lifetime
- 1993-12-17 KR KR1019950702950A patent/KR100377280B1/ko not_active Expired - Fee Related
- 1993-12-17 US US08/481,538 patent/US5648365A/en not_active Expired - Fee Related
- 1993-12-17 WO PCT/US1993/012300 patent/WO1994017040A1/en not_active Ceased
- 1993-12-17 AU AU60148/94A patent/AU679723B2/en not_active Ceased
- 1993-12-17 NZ NZ261414A patent/NZ261414A/en unknown
- 1993-12-17 HU HU9502195A patent/HUT72078A/hu unknown
- 1993-12-17 CA CA002152794A patent/CA2152794C/en not_active Expired - Fee Related
- 1993-12-17 DE DE69309310T patent/DE69309310T2/de not_active Expired - Fee Related
-
1994
- 1994-01-17 ZA ZA94317A patent/ZA94317B/xx unknown
- 1994-01-18 TW TW083100396A patent/TW243445B/zh active
- 1994-01-19 IL IL10836994A patent/IL108369A/en not_active IP Right Cessation
- 1994-01-20 MX MX9400563A patent/MX9400563A/es not_active IP Right Cessation
-
1995
- 1995-07-20 FI FI953506A patent/FI112474B/fi active
- 1995-07-20 NO NO952885A patent/NO305166B1/no not_active IP Right Cessation
-
1997
- 1997-04-21 GR GR970400848T patent/GR3023188T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU9502195D0 (en) | 1995-09-28 |
| NZ261414A (en) | 1997-06-24 |
| ES2102830T3 (es) | 1997-08-01 |
| FI953506L (fi) | 1995-07-20 |
| CA2152794A1 (en) | 1994-08-04 |
| TW243445B (enExample) | 1995-03-21 |
| GR3023188T3 (en) | 1997-07-30 |
| NO952885D0 (no) | 1995-07-20 |
| IL108369A (en) | 1999-08-17 |
| ATE150748T1 (de) | 1997-04-15 |
| KR100377280B1 (ko) | 2003-07-18 |
| DK0680470T3 (enExample) | 1997-04-28 |
| US5648365A (en) | 1997-07-15 |
| KR960700230A (ko) | 1996-01-19 |
| HUT72078A (en) | 1996-03-28 |
| FI953506A0 (fi) | 1995-07-20 |
| CA2152794C (en) | 1999-04-06 |
| JP3398748B2 (ja) | 2003-04-21 |
| IL108369A0 (en) | 1994-04-12 |
| ZA94317B (en) | 1994-08-18 |
| AU6014894A (en) | 1994-08-15 |
| EP0680470A1 (en) | 1995-11-08 |
| DE69309310D1 (de) | 1997-04-30 |
| NO305166B1 (no) | 1999-04-12 |
| WO1994017040A1 (en) | 1994-08-04 |
| AU679723B2 (en) | 1997-07-10 |
| EP0680470B1 (en) | 1997-03-26 |
| FI112474B (fi) | 2003-12-15 |
| NO952885L (no) | 1995-09-20 |
| DE69309310T2 (de) | 1997-11-06 |
| JPH08505870A (ja) | 1996-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR042051A1 (es) | Tratamiento combinado contra el cancer con un compuesto anti-cancerigeno activado por glutationa s- transferasa (gst) y otro tratamiento contra el cancer | |
| FI863664A0 (fi) | Emulsionskompositioner foer dosering av i vatten svaorloesliga joniserbara hydrofoba laekemedel. | |
| PA8433701A1 (es) | Inhibidores de metaloproteasas matriciales basados en fosfinatos. | |
| ES2058420T3 (es) | Preparados farmaceuticos combinados y su utilizacion como medicamentos antineoplasicos. | |
| BR9906581A (pt) | Processo para administração de taxano encapsulado em lipossomos | |
| KR970706830A (ko) | 2, 2'-디티오-비스(에탄설포네이트)(디메스나)와 조합된 시스플라틴의 조성물(composition of cisplatin in combination with 2, 2＇-dithio-bis (ethanesulfonate) (dimesna) | |
| CZ309247B6 (cs) | 40-O-(2-hydroxyethyl)rapamycin pro použití jako jediná účinná látka při léčení solidního nádoru | |
| MX9305934A (es) | Nuevo modificador de resistencia a drogas multiples. | |
| AR022860A1 (es) | Derivados de camptotecina que poseen actividad antitumoral | |
| UA42806C2 (uk) | Система для одночасного трансдермального введення кількох активних начал | |
| UY25074A1 (es) | Inhibidores de la farnesil proteina transferasa | |
| ATE495793T1 (de) | Antitumorzusammensetzungen welche ecteinascidin 743 enthalten | |
| ECSP045411A (es) | Derivados de quinolinona | |
| MX9400563A (es) | Diarilalquil piperidinas utiles como agentes en tumores resistentes a la administracion de farmacos multiples. | |
| ES2036553T3 (es) | Composiciones farmaceuticas que tienen actividad antineoplastica. | |
| PE20010747A1 (es) | Uso de dipiridamol o mopidamol para el tratamiento y prevencion de trastornos de la microcirculacion dependientes de fibrina | |
| ES2056699T3 (es) | Diaminoftalimidas substituidas y analogos. | |
| MX9301136A (es) | Composiciones que contienen psyllium. | |
| ES2168457T3 (es) | Composiciones farmaceuticas que comprenden una superoxido dismutasa. | |
| ES2180933T3 (es) | Inhibidor de la serina-proteasa. | |
| MX9300578A (es) | Inversion de la resistencia a multiples drogas por los tetraariletilenos. | |
| TR200201071T2 (tr) | Rar selektif retinoid antagonistleri kullanılarak anfizem tedavisi | |
| ES2166900T3 (es) | Derivados de ara-c. | |
| MX9205568A (es) | Composicion farmaceutica que contiene cantidades de 5-amino-1beta-d-ribofuranosil-imidazol-4-carboxamida. | |
| EA200100568A1 (ru) | Фармацевтические композиции в капсулах из гидроксипропилметилцеллюлозы |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| MM | Annulment or lapse due to non-payment of fees |